Ecole des Hautes Etudes en Santé Publique
11
1
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.2%
2 terminated/withdrawn out of 11 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Conception of an ICF Core Set for Systemic Sclerosis
Role: collaborator
Chemical and Microbiological Exposure of Women on Dairy Cattle Farms
Role: collaborator
Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean
Role: collaborator
Influence of Alcohol Marketing Stimuli in Adults With Regular Alcohol Consumption
Role: collaborator
CRESPI - Respiratory Health of Children in Daycare
Role: collaborator
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
Role: collaborator
Guaranteeing the Continuity of the Care Pathway for the Elderly Patient: Evaluation of a Territorial Approach of Clinical Pharmacy
Role: collaborator
Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units
Role: lead
Pragmatic Randomised Controlled Trial Evaluating Effectiveness of a Smoking Cessation e- Intervention " Tabac Info Service "
Role: lead
Perception of the Risks of Alcohol and Individual Vulnerabilities in Young Adults
Role: collaborator
Influence of Socio-Economic Factor on Net Survival in Patients With Multiple Sclerosis in France ( ECOVIMUS).
Role: collaborator
All 11 trials loaded